Here we present the recommendations for ototoxicity surveillance for childhood, adolescent and young adult cancer survivors.

Hearing loss

General recommendation

Who needs surveillance and how often should surveillance be performed?

What surveillance modality should be used?

What should be done when abnormalities are identified?


General recommendation

Green = strong recommendations to do; Orange = weak recommendation to do

See The Lancet Oncology for the publication.